![Teva and Natco Announce Launch of additional strengths for the Generic Version of Revlimid® (lenalidomide capsules), in the U.S. | Business Wire Teva and Natco Announce Launch of additional strengths for the Generic Version of Revlimid® (lenalidomide capsules), in the U.S. | Business Wire](https://mms.businesswire.com/media/20230306005799/en/739014/22/teva_RGB_JPEG.jpg)
Teva and Natco Announce Launch of additional strengths for the Generic Version of Revlimid® (lenalidomide capsules), in the U.S. | Business Wire
![ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business](https://mms.businesswire.com/media/20180914005613/en/678526/5/AJOVY+Image.jpg)
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
![Teva Canada Announces the Launch of (Pr)Teva-Tolterodine Tablets and (Pr) Teva-Tolterodine LA Extended Release Capsules, Generics of (Pr)Detrol® and (Pr)Detrol LA® Teva Canada Announces the Launch of (Pr)Teva-Tolterodine Tablets and (Pr) Teva-Tolterodine LA Extended Release Capsules, Generics of (Pr)Detrol® and (Pr)Detrol LA®](http://photos.newswire.ca/images/20151215_C6454_PHOTO_EN_564829.jpg)
Teva Canada Announces the Launch of (Pr)Teva-Tolterodine Tablets and (Pr) Teva-Tolterodine LA Extended Release Capsules, Generics of (Pr)Detrol® and (Pr)Detrol LA®
![USFDA: Teva Pharmaceutical recalls 38,858 bottles of drugs made by Emcure Pharmaceuticals in US market - The Economic Times USFDA: Teva Pharmaceutical recalls 38,858 bottles of drugs made by Emcure Pharmaceuticals in US market - The Economic Times](https://img.etimg.com/thumb/width-1200,height-900,imgsize-22194,resizemode-1,msid-35482570/industry/healthcare/biotech/pharmaceuticals/teva-pharmaceutical-recalls-38858-bottles-of-drugs-made-by-emcure-pharmaceuticals-in-us-market.jpg)